Hollingdale M R, Nardin E H, Tharavanij S, Schwartz A L, Nussenzweig R S
J Immunol. 1984 Feb;132(2):909-13.
Plasmodium falciparum and P. vivax sporozoites were observed to invade cultured human hepatoma cells in vitro. Monoclonal antibodies to the circumsporozoite (CS) protein of each of these malarial species blocked invasion. Inhibition was species-specific, but was independent of the geographic origin of each strain. Because these monoclonal antibodies have been shown to diminish or abolish sporozoite infectivity to susceptible primate hosts, it is suggested that inhibition of invasion of sporozoites (ISI) into cultured cells may represent in in vitro assay for protective antibodies. This was confirmed by the finding that serum taken from volunteers immune to sporozoite challenge also totally blocked sporozoite invasion. The ISI assay also detected naturally acquired invasive-neutralizing antibodies in areas endemic for malaria. This ISI assay may therefore be useful in determining the incidence of inhibitory anti-sporozoite antibodies in general populations, and allow the monitoring of the effect of an anti-malarial vaccine using sporozoite-derived antigens.
体外观察到恶性疟原虫和间日疟原虫的子孢子可侵入培养的人肝癌细胞。针对这两种疟原虫环子孢子(CS)蛋白的单克隆抗体可阻断入侵。抑制作用具有种特异性,但与每个菌株的地理来源无关。由于这些单克隆抗体已被证明可降低或消除子孢子对易感灵长类宿主的感染性,因此有人提出,子孢子入侵抑制试验(ISI)可能是一种检测保护性抗体的体外试验。志愿者血清对子孢子攻击具有免疫力,该血清也完全阻断子孢子入侵,这一发现证实了上述观点。ISI试验还检测到疟疾流行地区自然获得的侵袭中和抗体。因此,这种ISI试验可能有助于确定普通人群中抑制性子孢子抗体的发生率,并可监测使用子孢子衍生抗原的抗疟疾疫苗的效果。